Insider Selling: Arteris (NASDAQ:AIP) Major Shareholder Sells 9,000 Shares of Stock

Arteris, Inc. (NASDAQ:AIP - Get Free Report) major shareholder Bayview Legacy, Llc sold 9,000 shares of Arteris stock in a transaction that occurred on Tuesday, March 10th. The shares were sold at an average price of $14.66, for a total value of $131,940.00. Following the sale, the insider directly owned 9,229,071 shares in the company, valued at $135,298,180.86. The trade was a 0.10% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Major shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.

• 3 Straightforward ETF Plays to Build AI Exposure Into a Portfolio

Bayview Legacy, Llc also recently made the following trade(s):

• On Monday, March 9th, Bayview Legacy, Llc sold 41,000 shares of Arteris stock. The shares were sold at an average price of $14.21, for a total value of $582,610.00.
• On Tuesday, February 10th, Bayview Legacy, Llc sold 2,756 shares of Arteris stock. The stock was sold at an average price of $15.03, for a total value of $41,422.68.
• On Monday, February 9th, Bayview Legacy, Llc sold 47,244 shares of Arteris stock. The stock was sold at an average price of $15.21, for a total value of $718,581.24.
• On Thursday, January 15th, Bayview Legacy, Llc sold 17,884 shares of Arteris stock. The shares were sold at an average price of $17.84, for a total value of $319,050.56.
• On Tuesday, January 13th, Bayview Legacy, Llc sold 2,116 shares of Arteris stock. The shares were sold at an average price of $17.79, for a total value of $37,643.64.
• On Thursday, January 8th, Bayview Legacy, Llc sold 50,000 shares of Arteris stock. The stock was sold at an average price of $16.58, for a total value of $829,000.00.

Arteris Stock Down 0.9%

---

---

Arteris stock traded down $0.13 during mid-day trading on Thursday, hitting $15.49. 19,383 shares of the company were exchanged, compared to its average volume of 480,623. The company has a market capitalization of $704.19 million, a PE ratio of -18.86 and a beta of 1.45. The business has a fifty day moving average of $15.84 and a 200 day moving average of $14.01. Arteris, Inc. has a 1-year low of $5.46 and a 1-year high of $19.85.

• Small Cap, Big Potential: 3 Tech Disruptors You Should Know About

Arteris (NASDAQ:AIP - Get Free Report) last issued its earnings results on Thursday, February 12th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.03. The firm had revenue of $20.14 million during the quarter, compared to analyst estimates of $18.55 million. Research analysts expect that Arteris, Inc. will post -0.73 earnings per share for the current year.

Arteris News Summary

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Recent quarterly results showed Arteris beat expectations: EPS of ($0.05) vs. consensus ($0.08) and revenue of $20.14M vs. $18.55M, signaling better-than-expected near-term performance (this remains a positive fundamental datapoint for investors).
• Neutral Sentiment: The MSN piece titled "Why Arteris, Inc. (AIP) is in focus" highlights recent trading activity and investor attention; it may be amplifying interest but does not introduce new company-specific fundamentals. Article Link
• Neutral Sentiment: Reported short-interest data for early March appears to be anomalous/invalid (shows 0 shares and NaN changes). Given the questionable reporting, this item is unlikely to be a reliable driver of price action until corrected by an authoritative update.
• Negative Sentiment: Insider/major-holder selling: CEO K. Charles Janac and major shareholder Bayview Legacy, LLC executed sales on March 9–10 totaling 50,000 shares (41,000 @ $14.21 and 9,000 @ $14.66) for combined proceeds of ~$714,550. These filings and the size of the sales are prompting investor concern about insider liquidity and near-term share pressure. SEC filings: Janac Filing and Bayview Filing

Wall Street Analysts Forecast Growth

• 5 Semiconductor stocks under $10

Several brokerages have weighed in on AIP. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Arteris in a research note on Wednesday, January 21st. Rosenblatt Securities reiterated a "buy" rating and issued a $20.00 target price on shares of Arteris in a research note on Friday, February 13th. Finally, Northland Securities set a $24.00 target price on Arteris in a report on Friday, February 13th. Two research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Arteris presently has a consensus rating of "Hold" and an average target price of $20.17.

View Our Latest Report on AIP

Institutional Investors Weigh In On Arteris

A number of institutional investors and hedge funds have recently modified their holdings of AIP. Westerly Capital Management LLC lifted its holdings in Arteris by 109.6% in the third quarter. Westerly Capital Management LLC now owns 1,425,000 shares of the company's stock valued at $14,392,000 after buying an additional 745,000 shares during the period. Nuveen LLC grew its holdings in Arteris by 872.3% during the 4th quarter. Nuveen LLC now owns 737,281 shares of the company's stock worth $11,428,000 after acquiring an additional 661,454 shares during the period. Goldman Sachs Group Inc. grew its holdings in Arteris by 144.7% during the 4th quarter. Goldman Sachs Group Inc. now owns 1,012,670 shares of the company's stock worth $15,696,000 after acquiring an additional 598,840 shares during the period. Granahan Investment Management LLC raised its position in shares of Arteris by 725.7% during the 3rd quarter. Granahan Investment Management LLC now owns 621,625 shares of the company's stock valued at $6,278,000 after acquiring an additional 546,341 shares during the last quarter. Finally, Informed Momentum Co LLC bought a new stake in shares of Arteris during the 4th quarter valued at $5,755,000. 64.36% of the stock is owned by institutional investors.

Arteris Company Profile

(Get Free Report)

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company's core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.

Further Reading

• Five stocks we like better than Arteris
• How China Accidentally Created Its Own Rare Earth Rival
• Nvidia CEO Issues Bold Tesla Call
• Do this before SpaceX IPOs or be sorry
• The Market Just Split in Two (URGENT)
• Central banks just did something they haven’t done since 1967

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].